1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
REPORT OVERVIEW
This report offers market size & forecast data for pharmaceutical packaging market in Europe. The revenue generated from the sale of pharmaceutical packaging materials and products are includes in the report. Revenue generated by service providers are excluded from the scope of the report. This report provides a comprehensive and current market scenario of the Europe pharmaceutical packaging, including the Europe pharmaceutical packaging market size, anticipated market forecast, relevant market segmentations, and industry trends.The study considers a detailed scenario of the present pharmaceutical packaging market and its market dynamics for 2023−2028 in Europe. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
MARKET DEFINITION
Pharmaceutical packaging is the packaging processes for pharmaceutical preparations, and it is an integral part of the pharmaceutical product. Packaging is often involved in dosing, dispensing, and use of the pharmaceutical product. Packaging plays a significant role in keeping the drug safe and one of the important aspect is that, the material used for the packaging the drugs should remain safe as it should not react with the drug packaged.KEY HIGHLIGHTS
- The Europe pharmaceutical packaging market was valued at $25.58 billion in 2022 and is projected to reach at $33.97 billion in 2028, with a compound annual growth rate (CAGR) of 4.84%, during the study period.
- In 2022, Germany accounted for a significant market share of 20.21% followed by the UK with 16.05% and then France with 14.93% in Europe Pharmaceuticals packaging market which is owing to increasing demand for prescription drugs, presence of leading pharmaceutical players, well-developed infrastructure, and high investments in drug development.
- Primary Packaging accounted for the highest share of more than 70% in the Europe Pharmaceutical packaging market due to attributable to growing demand of blister packs, bottles, vials, ampoules, pouches, sachet, and bags with the increasing demand for pharmaceuticals.
- Based on primary packaging type, the strips & blister packaging segment accounted for a share of more than 33% market share in the Europe pharmaceutical packaging market and dominated the other segments due to its wide usage as an essential primary packaging element for pharmaceutical products.
- Based on material type, the paper segment accounts for a share of more than 38% in the Europe Pharmaceutical packaging market share that can be attributable to its highest demand in secondary & tertiary packaging and increasing demand for recyclable materials.
- The pharmaceutical and biotech companies accounted for highest share of more than 46% in the Europe Pharmaceutical packaging market which is owing to growing aged population, growing demand for branded drugs, OTC drugs and specialty medicines, increasing patent expiring drugs, and higher drug prices.
- Amcor, Aptar Group, Berry Global, Laser Gerresheimer and WestRock are the leading players in the Europe Pharmaceutical Packaging market. The market offers tremendous growth opportunities for existing and future/emerging players because of innovations in oncology, autoimmune, and diabetes treatment, chronic ailments and rare diseases.
REPORT HIGHLIGHTS
PRODUCT SEGMENTATION & FORECAST
- Packaging type
- Primary
- Secondary
- Tertiary
- Primary Packaging type
- Ampoules
- Vials
- Blisters & Strip
- Bottles & Jars
- Containers & Tubes
- Pouches & Sachets
- Others
- Material type
- Paper
- Glass
- Plastic
- Others
- End-user type
- Pharmaceuticals & Biotech Companies
- CMOs/CDMOs
- Others
MARKET STRUCTURE
- Market Dynamics
- Competitive Landscape of Pharmaceutical packaging Market
- Key Vendors
- Other Prominent Vendors
APPENDIX
- Research Methodology
- Abbreviations
Table of Contents
CHAPTER - 1: Pharmaceutical Packaging Market Overview- Executive Summary
- Introduction
- Key Findings
- Europe: Projected Revenue of Pharmaceutical Packaging (2022-2028; $Billions)
- Europe: Projected Revenue by Packaging type (2022-2028; $Billions)
- Primary Packaging
- Secondary Packaging
- Tertiary Packaging
- Europe: Projected Revenue by Primary Packaging type (2022-2028; $Billions)
- Ampoules Packaging
- Vials Packaging
- Strip & Blister Packaging
- Bottles & Jars
- Containers & Tubes
- Sachets & Pouches
- Others
- Europe: Projected Revenue by Material type (2022-2028; $Billions)
- Paper
- Glass
- Plastic
- Others
- Europe: Projected Revenue by End-user type (2022-2028; $Billions)
- Pharma & Biotech Companies
- CMOs/CDMOs
- Others
- Germany: Projected Revenue of Pharmaceutical Packaging Market (2022-2028; $Billions)
- UK: Projected Revenue of Pharmaceutical Packaging Market (2022-2028; $Billions)
- France: Projected Revenue of Pharmaceutical Packaging Market (2022-2028; $Billions)
- Italy: Projected Revenue of Pharmaceutical Packaging Market (2022-2028; $Billions)
- Spain: Projected Revenue of Pharmaceutical Packaging Market (2022-2028; $Billions)
- Pharmaceutical Packaging Market Drivers
- Pharmaceutical Packaging Market Trends
- Pharmaceutical Packaging Market Constraints
- Pharmaceutical Packaging - Competitive Landscape
- Pharmaceutical Packaging - Key Players
- Pharmaceutical Packaging - Key Company Profiles
- Pharmaceutical Packaging - Key Strategic Recommendations
- Research Methodology
- Abbreviations
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
